USD 0.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2022 | -24.99 Million USD | 66.64% |
2021 | -74.92 Million USD | -131.21% |
2020 | -32.4 Million USD | -230.4% |
2019 | -9.8 Million USD | -2043.51% |
2018 | -457.54 Thousand USD | 82.9% |
2017 | -2.67 Million USD | -309.42% |
2016 | -653.46 Thousand USD | 20.17% |
2015 | -818.54 Thousand USD | -154.15% |
2014 | -322.06 Thousand USD | 6.28% |
2013 | -343.63 Thousand USD | -148820.7% |
2012 | -230.75 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 100.0% |
2022 Q4 | -4.99 Million USD | 16.52% |
2022 Q2 | -7.25 Million USD | 14.83% |
2022 FY | -24.99 Million USD | 66.64% |
2022 Q1 | -8.52 Million USD | 54.59% |
2022 Q3 | -5.98 Million USD | 17.58% |
2021 Q1 | -17.55 Million USD | -288.86% |
2021 FY | -74.92 Million USD | -131.21% |
2021 Q4 | -18.76 Million USD | -80.82% |
2021 Q3 | -10.37 Million USD | -406.17% |
2021 Q2 | 3.39 Million USD | 119.31% |
2020 Q1 | -4.63 Million USD | 0.0% |
2020 FY | -32.4 Million USD | -230.4% |
2020 Q4 | -4.51 Million USD | 74.97% |
2020 Q3 | -18.03 Million USD | -597.68% |
2020 Q2 | -2.58 Million USD | 44.26% |
2019 FY | -9.8 Million USD | -2043.51% |
2018 FY | -457.54 Thousand USD | 82.9% |
2017 FY | -2.67 Million USD | -309.42% |
2016 FY | -653.46 Thousand USD | 20.17% |
2015 Q4 | -126.94 Thousand USD | 0.0% |
2015 Q3 | -126.94 Thousand USD | 50.56% |
2015 Q2 | -256.78 Thousand USD | 0.0% |
2015 Q1 | -256.78 Thousand USD | -375.03% |
2015 FY | -818.54 Thousand USD | -154.15% |
2014 Q1 | -91.61 Thousand USD | 0.0% |
2014 Q4 | -54.05 Thousand USD | 0.0% |
2014 Q2 | -91.61 Thousand USD | 0.0% |
2014 FY | -322.06 Thousand USD | 6.28% |
2014 Q3 | -54.05 Thousand USD | 41.0% |
2013 FY | -343.63 Thousand USD | -148820.7% |
2012 FY | -230.75 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
American Bio Medica Corporation | -1.41 Million USD | -1672.624% |
Arrayit Corporation | -3.31 Million USD | -653.832% |
Atlantic International Corp. | -5.62 Million USD | -344.133% |
Biocept, Inc. | -32.08 Million USD | 22.106% |
Bioqual, Inc. | 483.48 Thousand USD | 5269.593% |
CardioGenics Holdings Inc | -1.91 Million USD | -1204.268% |
DermTech, Inc. | -100.88 Million USD | 75.226% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 101.234% |
HTG Molecular Diagnostics, Inc. | -21.59 Million USD | -15.743% |
iMD Companies, Inc. | -200.63 Thousand USD | -12357.386% |
IDenta Corp. | 14.64 Thousand USD | 170777.411% |
Interpace Biosciences, Inc. | 802 Thousand USD | 3216.459% |
Integrative Health Technologies, Inc. | 38.68 Thousand USD | 64702.342% |
InVitro International | 1553.00 USD | 1609501.159% |
Lumos Diagnostics Holdings Limited | -8.59 Million USD | -190.899% |
Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -42910.05% |
Medical Imaging Corp. | -3.02 Million USD | -726.788% |
NovelStem International Corp. | -4.18 Million USD | -496.9% |
Optigenex Inc. | -2.89 Million USD | -762.528% |
PharmChem, Inc. | 845.1 Thousand USD | 3057.513% |
Proteome Sciences plc | -2.44 Million USD | -923.086% |
Response Genetics, Inc | -20.18 Million USD | -23.831% |
Rennova Health, Inc. | -3.29 Million USD | -658.991% |
RushNet, Inc. | -607.02 Thousand USD | -4017.438% |
ScreenPro Security Inc. | -2.24 Million USD | -1011.454% |
Stella Diagnostics Inc. | -5.7 Million USD | -337.921% |
StageZero Life Sciences Ltd. | -11.41 Million USD | -118.95% |